You have 9 free searches left this month | for more free features.

G-CSF

Showing 26 - 50 of 6,716

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Optimization of Haploidentical Hematopoietic Stem Cell

Not yet recruiting
  • Hematological Malignancy
  • ATG
  • Post-transplantation cyclophosphamide
  • Beijing, Beijing, China
    People's Hospital of Peking University
Nov 28, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Feb 17, 2022

Granulocyte Colony-Stimulating Factor, PD-1 Inhibitor Trial in Guangzhou (PEG-rhG-CSF)

Recruiting
  • Granulocyte Colony-Stimulating Factor
  • PD-1 Inhibitor
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2022

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

Active, not recruiting
  • Multiple Myeloma
  • BL-8040 1.25mg/kg + G-CSF
  • Placebo +G-CSF
  • Los Angeles, California
  • +17 more
Jun 14, 2022

Follicular and Blood G-CSF During a Natural Cycle of IVF

Suspended
  • Infertility
  • Blood test
  • Montréal, Quebec, Canada
    Ovo Fertilité
Jan 7, 2022

Frailty Trial in Boynton Beach (GMFFP)

Enrolling by invitation
  • Frailty
  • Boynton Beach, Florida
    South Florida Bone Marrow/Stem Cell Transplant Institute DBA Mah
May 5, 2022

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Fanconi Anemia Trial in Paris (G-CSF, Plerixafor)

Completed
  • Fanconi Anemia
  • Paris, France
    Hôpital necker-Enfants malades
Dec 20, 2021

Healthy Volunteers Trial in Strasbourg (Lenograstim)

Recruiting
  • Healthy Volunteers
  • Strasbourg, France
    CHRU Strasbourg
Oct 25, 2022

Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)

Recruiting
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Intermittent Claudication, PAD, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No PB-MNC therapy)

Recruiting
  • Intermittent Claudication
  • +2 more
  • PB-MNC therapy
  • No PB-MNC therapy
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital, Mahidol University
Dec 16, 2021

PAD, Critical Limb Ischemia, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No-PB-MNC therapy)

Recruiting
  • PAD
  • +2 more
  • PB-MNC therapy
  • No-PB-MNC therapy
  • Bangkoknoi, Bangkok, Thailand
    Vascular Surgery, Siriraj Hospital, Mahidol University
Dec 16, 2021

Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Jun 8, 2023

Anterior Myocardial Infarction, Heart Failure Trial in Rome (rhu G-CSF, optimal standard of care, Myocardial Contrast

Withdrawn
  • Anterior Myocardial Infarction
  • Heart Failure
  • rhu G-CSF
  • +2 more
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli
Mar 28, 2022

Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))

Completed
  • Healthy
  • AMD 3100 (Mozobil plerixafor)
  • Granulocyte colony-stimulating factor (G-CSF)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)

Recruiting
  • Allogeneic Granulocyte Donation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 7, 2023

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • AML Stage, Adult
  • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
  • Xiamen, Fujian, China
    Bing Xu
Oct 29, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

Recruiting
  • Pancreatic Cancer
  • Sydney, New South Wales, Australia
  • +2 more
Oct 19, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Healthy Volunteers Trial in Hannover (CSL324, Placebo)

Recruiting
  • Healthy Volunteers
  • Hannover, Germany
    Fraunhofer Institute for Toxicology and Experimental Medicine
Jan 28, 2023